Given these findings, tau-targeted theranostic agents, such as radioiodinated Azure-A, which binds to aggregated tau and demonstrates excellent brain uptake with minimal toxicity, could serve as a dual-purpose imaging and treatment tool in a subset of gliomas [28]. Here, MAPT is linked to central nervous system cancer.